ClinicalTrials.Veeva

Menu

Quality of Sexual Life of PrEP Users (PREP-QUAL-VS)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Enrolling

Conditions

Adult
HIV Pre-exposure Prophylaxis Use

Treatments

Other: anonymous self-administered online questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT06286527
EssaiClinique_PREP-QUAL-VS

Details and patient eligibility

About

The study will recruit participants on the occasion of their visit in a sexual health center or another HIV pre-exposure prophylaxis (PrEP) facility in France.

PrEP users will be proposed to fill a self-administered, online, anonymous questionnaire regarding how they perceive different fields of their sexual life, and how they perceive that PrEP has an impact on the quality of sexual life.

Full description

PrEP aims to protect against HIV; more broadly, PrEP is a holistic process, addressing vaccination (hepatitis A, hepatitis B, human papillomavirus, MPox), sexually transmitted infection diagnosis, mental health, issues related to psychoactive substance use, etc.

This process is likely to impact not only "classical" health areas, but also fields concerning more widely the quality of life.

In particular, the investigators emit the hypothesis that PrEP is associated with an increase of the quality of sexual life.

the investigators have therefore designed a study based on a self-administered anonymous questionnaire to explore how PrEP user evaluate their quality of sexual life and how they perceive the impact of PrEP on this topic.

Adult PrEP users will be recruited through billboard in sexual health center or another PrEP facility in France. A QR (quick response) code will be displayed, giving access to the questionnaire.

Participation to the study is limited to fill once the questionnaire.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • current PrEP use
  • adult

Exclusion criteria

  • unwilling to participate

Trial design

1,000 participants in 1 patient group

adult PrEP users
Treatment:
Other: anonymous self-administered online questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Olivier Epaulard, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems